CRTX.L
CRISM Therapeutics Corporation focuses on drug delivery technology to improve the clinical performance of cancer drugs as treatments for solid tumors. Its lead product, ChemoSeed that can be implanted directly into a tumor or the resection margin following the removal of a tumor, ensuring effective therapeutic concentrations of chemotherapy drugs directly reach the tumor tissue. Its ChemoSeed used for treatment of gliomas, a brain tumor. The company was founded in 2016 and is based in Road Town, the British Virgin Islands.
Industry
Biotechnology
IPO Date
2003-10-17
Stock Exchange
LSE
Ticker
CRTX.L
According to CRISM Therapeutics Corporation’s latest financial reports and current stock price. The company's current Current Ratio is 3.65. This represents a change of -34.85% compared to the average of 5.60 of the last 4 quarters.
The mean historical Current Ratio of CRISM Therapeutics Corporation over the last ten years is 4.04. The current 3.65 Current Ratio has changed 8.93% with respect to the historical average. Over the past ten years (40 quarters), CRTX.L's Current Ratio was at its highest in in the December 2023 quarter at 7.23. The Current Ratio was at its lowest in in the June 2016 quarter at 0.
Average
4.04
Median
4.76
Minimum
0.65
Maximum
7.23
Discovering the peaks and valleys of CRISM Therapeutics Corporation Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 415.07%
Maximum Annual Current Ratio = 7.23
Minimum Annual Increase = -87.70%
Minimum Annual Current Ratio = 0.65
| Year | Current Ratio | Change |
|---|---|---|
| 2024 | 4.96 | -31.45% |
| 2023 | 7.23 | 51.89% |
| 2022 | 4.76 | -8.48% |
| 2021 | 5.20 | 10.10% |
| 2020 | 4.72 | 415.07% |
| 2019 | 0.92 | 40.82% |
| 2018 | 0.65 | -87.70% |
| 2017 | 5.29 | 102.02% |
The current Current Ratio of CRISM Therapeutics Corporation (CRTX.L) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
5.65
5-year avg
5.37
10-year avg
4.04
CRISM Therapeutics Corporation’s Current Ratio is greater than Tissue Regenix Group plc (3.46), greater than Theracryf Plc (3.11), greater than MyHealthChecked PLC (2.54), greater than Proteome Sciences plc (0.11), less than N4 Pharma Plc (23.55), greater than Oxford BioDynamics Plc (2.59), greater than Cizzle Biotechnology Holdings Plc (1.20), greater than Roquefort Therapeutics plc (0.63), greater than Chill Brands Group PLC (0.80), less than Feedback plc (10.49),
| Company | Current Ratio | Market cap |
|---|---|---|
| 3.46 | N/A | |
| 3.11 | N/A | |
| 2.54 | N/A | |
| 0.11 | N/A | |
| 23.55 | N/A | |
| 2.59 | N/A | |
| 1.20 | N/A | |
| 0.63 | N/A | |
| 0.80 | N/A | |
| 10.49 | N/A |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like CRISM Therapeutics Corporation using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like CRISM Therapeutics Corporation or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is CRISM Therapeutics Corporation's Current Ratio?
How is the Current Ratio calculated for CRISM Therapeutics Corporation (CRTX.L)?
What is the highest Current Ratio for CRISM Therapeutics Corporation (CRTX.L)?
What is the 3-year average Current Ratio for CRISM Therapeutics Corporation (CRTX.L)?
What is the 5-year average Current Ratio for CRISM Therapeutics Corporation (CRTX.L)?
How does the current Current Ratio for CRISM Therapeutics Corporation (CRTX.L) compare to its historical average?